Objective: The lack of prognostic biomarkers in patients with amyotrophic lateral sclerosis (ALS) induced researchers to develop clinical evaluation tools for stratification and survival prediction. We assessed the correlation between patterns of functional involvement, considered as a cumulative number of body regions involved, and overall survival in a population-based series of patients with ALS (PARALS). Methods: We derived the functional involvement of four body regions at diagnosis using ALSFRS-R subscores for bulbar, upper limbs, lower limbs and respiratory/thoracic regions. We analysed the effect of number of body regions involved (NBRI) at diagnosis on overall survival, adjusting for age at onset, sex, site of onset, diagnostic del...
Our objectives were: (1) to identify independent prognostic factors to determine a survival score fo...
International audienceObjectives: Amyotrophic lateral sclerosis (ALS) is a rare disease with heterog...
Although several prognostic factors have been identified in ALS, there remains some discordance conc...
Amyotrophic lateral sclerosis (ALS) is a devastating neurological syndrome in which motor neurons de...
Background and purpose The prediction of disease course is one of the main targets of amyotrophic la...
Background and purpose: Sporadic amyotrophic lateral sclerosis (sALS) is a disease with a focal clin...
Objective: The heterogeneity of amyotrophic lateral sclerosis (ALS) survival duration, which varies ...
Abstract Background Amyotrophic lateral sclerosis (ALS) a highly heterogeneous neurodegenerative con...
OBJECTIVE: To measure survivorship and predictors of prognosis of amyotrophic lateral sclerosis (ALS...
Amyotrophic lateral sclerosis (ALS) has a fatal outcome in about three years, but survival is known ...
BACKGROUND: Despite the inevitability of disease progression in amyotrophic lateral sclerosis, there...
Introduction/Aims Rate of disease progression (ΔFS), measured as change in the revised Amyotrophi...
Amyotrophic lateral sclerosis is a fatal neurodegenerative disease characterized by progressive musc...
The natural history of amyotrophic lateral sclerosis (ALS) and patient risk stratification are areas...
Estimating survival in amyotrophic lateral sclerosis (ALS) is challenging due to heterogeneity in cl...
Our objectives were: (1) to identify independent prognostic factors to determine a survival score fo...
International audienceObjectives: Amyotrophic lateral sclerosis (ALS) is a rare disease with heterog...
Although several prognostic factors have been identified in ALS, there remains some discordance conc...
Amyotrophic lateral sclerosis (ALS) is a devastating neurological syndrome in which motor neurons de...
Background and purpose The prediction of disease course is one of the main targets of amyotrophic la...
Background and purpose: Sporadic amyotrophic lateral sclerosis (sALS) is a disease with a focal clin...
Objective: The heterogeneity of amyotrophic lateral sclerosis (ALS) survival duration, which varies ...
Abstract Background Amyotrophic lateral sclerosis (ALS) a highly heterogeneous neurodegenerative con...
OBJECTIVE: To measure survivorship and predictors of prognosis of amyotrophic lateral sclerosis (ALS...
Amyotrophic lateral sclerosis (ALS) has a fatal outcome in about three years, but survival is known ...
BACKGROUND: Despite the inevitability of disease progression in amyotrophic lateral sclerosis, there...
Introduction/Aims Rate of disease progression (ΔFS), measured as change in the revised Amyotrophi...
Amyotrophic lateral sclerosis is a fatal neurodegenerative disease characterized by progressive musc...
The natural history of amyotrophic lateral sclerosis (ALS) and patient risk stratification are areas...
Estimating survival in amyotrophic lateral sclerosis (ALS) is challenging due to heterogeneity in cl...
Our objectives were: (1) to identify independent prognostic factors to determine a survival score fo...
International audienceObjectives: Amyotrophic lateral sclerosis (ALS) is a rare disease with heterog...
Although several prognostic factors have been identified in ALS, there remains some discordance conc...